- Home
- NAN vs LFCR Comparison
NAN vs LFCR Comparison
Compare NAN & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAN
- LFCR
- Stock Information
- Founded
- NAN 1999
- LFCR 1986
- Country
- NAN United States
- LFCR United States
- Employees
- NAN N/A
- LFCR N/A
- Industry
- NAN Investment Managers
- LFCR Biotechnology: Pharmaceutical Preparations
- Sector
- NAN Finance
- LFCR Health Care
- Exchange
- NAN Nasdaq
- LFCR Nasdaq
- Market Cap
- NAN 349.4M
- LFCR 308.8M
- IPO Year
- NAN N/A
- LFCR N/A
- Fundamental
- Price
- NAN $11.11
- LFCR $7.25
- Analyst Decision
- NAN
- LFCR Buy
- Analyst Count
- NAN 0
- LFCR 4
- Target Price
- NAN N/A
- LFCR $8.00
- AVG Volume (30 Days)
- NAN 74.6K
- LFCR 131.6K
- Earning Date
- NAN 01-01-0001
- LFCR 08-07-2025
- Dividend Yield
- NAN 4.37%
- LFCR N/A
- EPS Growth
- NAN N/A
- LFCR N/A
- EPS
- NAN N/A
- LFCR N/A
- Revenue
- NAN N/A
- LFCR $130,309,000.00
- Revenue This Year
- NAN N/A
- LFCR $1.64
- Revenue Next Year
- NAN N/A
- LFCR $2.91
- P/E Ratio
- NAN N/A
- LFCR N/A
- Revenue Growth
- NAN N/A
- LFCR 7.23
- 52 Week Low
- NAN $9.11
- LFCR $3.68
- 52 Week High
- NAN $11.34
- LFCR $8.85
- Technical
- Relative Strength Index (RSI)
- NAN 41.86
- LFCR 37.64
- Support Level
- NAN $10.96
- LFCR $6.79
- Resistance Level
- NAN $11.05
- LFCR $7.51
- Average True Range (ATR)
- NAN 0.09
- LFCR 0.30
- MACD
- NAN -0.01
- LFCR -0.10
- Stochastic Oscillator
- NAN 39.02
- LFCR 18.15
About NAN Nuveen New York Quality Municipal Income Fund
Nuveen New York Quality Municipal Income Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal, New York State and New York City income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.